Last update May 21, 2021
Vasodilator and cardiac stimulant that is marketed in association with other medications with purported and unproven properties such as to improve brain function, dizziness, and certain mental disorders.
There is no published clear evidence of its efficacy.
At the date of the last update, the authors did not find any published data on its excretion in breast milk.
The limited pharmacokinetic data available (low molecular weight, high pKa) make it likely that it may be transferred to breast milk in a possibly significant amount.
Product with very few bibliographic references, marketed in few countries.
Considered as a drug of low therapeutic utility (SEFAP 2012, INSALUD 2001) and even of risk to health (ANSM 2015).
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.
In general, multiple drug combinations are not recommended, nor are drugs of unproven efficacy.
We do not have alternatives for Heptaminol Hydrochloride.
Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.